Lv4
480 积分 2021-09-15 加入
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
25天前
已完结
Efficacy and Safety of PD-1/L1 Inhibitors Combined with Anlotinib versus PD-1 /L1 Inhibitors Combined with Bevacizumab in Second-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients: A Comparative Cohort Study
26天前
已完结
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
1个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
1个月前
已完结
At the Crossroads of TNF α Signaling and Cancer
2个月前
已完结
Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironment
2个月前
已完结
Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes
2个月前
已完结
Dendritic cell maturation in cancer
2个月前
已完结
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
2个月前
已完结
Interleukin-6 (IL-6)-associated tumor microenvironment remodelling and cancer immunotherapy
2个月前
已完结
皖公网安备34019202002308
